Earlymarket
Venture capitalPre-Seed–Series A
Investment thesis
Earlymarket backs early-stage technology startups, with focus areas that include the energy transition, the future of agriculture, and personalised healthcare, among others. Its portfolio reflects an interest in deeptech and frontier science ventures such as lithium mining and refining, organ-on-a-chip cancer modelling, and nanorobotics for disease detection.
Source: firm website, verified Aug 7, 2026.
What they invest in
from 4 of 14 portfolio companiesBiotech ×2Consumer ×2Medical Devices ×2Mobility & Transportation ×2Deep Tech ×1Digital Health ×1Hardware ×1Healthtech ×1
HQs:United Kingdom×2
Investments · 14 tracked
founders shown can be your intro pathBeeline makes compact GPS navigation devices (Moto II and Velo 2) and a companion app offering turn-by-turn directions, speed, and ride tracking for motorcyclists and cyclists.
ConsumerHardwareMobility & Transportation
Mark(Co-founder)Tom(Co-founder)Tom Putnam(Founder)in
Co-investorsTrue.Bain Capital
Developing the UK's first integrated lithium mining and refining operation.
Navigation technology for cyclists and motorcyclists.
Navigation technology for cyclists and motorcyclists.
Navigation technology for cyclists and motorcyclists.
The world's largest moderated database of helicopter landing sites.
Helipaddy operates a database and mobile app of off-airfield helicopter landing sites, listing over 12,000 pads across more than 60 countries, including hotels, restaurants, and vineyards.
ConsumerMobility & TransportationTravel & Hospitality
Developing the UK's first integrated lithium mining and refining operation.
Developing nanorobot technology for early disease detection.
Developing nanorobot technology for early disease detection.
Nanovery develops DNA-based nanorobotic sensors that quantify nucleic acid sequences, such as RNA therapeutics and biomarkers, in liquid samples using a standard plate reader.
BiotechDeep TechHealthtechMedical DevicesLondon, GB
Jerzy Kozyra(CEO)inMun Ching Lee(Cofounder)in
Co-investorsEntrepreneur First
Using organ-on-a-chip and AI to model cancer progression.
Using organ-on-a-chip and AI to model cancer progression.
Pear Bio delivers precision medicine tests and therapeutics for patients with hard-to-treat cancers by creating personalized treatment predictions from tumor biopsies and developing novel targeted therapies.
BiotechDigital HealthMedical Devices
Duleek Ranatunga(Founder)in
Co-investorsCompoundFly VenturesHoxton VenturesOctopus VenturesSoftBank Investment Advisers’ Emerge ProgramWavemaker Three-Sixty Health
Portfolio news
latest coverage across their companies
Beeline · stocktitan.net · Aug 14, 2026
Frequently asked questions
- How many investments has Earlymarket made?
- Earlymarket has 14 tracked investments.
- What stage does Earlymarket invest at?
- Earlymarket invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Earlymarket focus on?
- Earlymarket focuses on AgTech, AI & Machine Learning, Biotech, Climate Tech, Deep Tech, Energy, Healthtech, Robotics.
- Who does Earlymarket co-invest with?
- Earlymarket most often shares deals with Compound, Entrepreneur First, Fly Ventures, among 8 tracked co-investors.
Similar investors
Future Positive Capital is a European deep-tech fund that ties its entire thesis to the Future Cones foresight framework, explicitly focusing on preferable futures and positioning itself as a futures-thinking, systems-change VC rather than a generic climate or impact fund. The firm hard-wires impact into its economics by contractually indexing more than 100% of partners' carried interest to portfolio companies achieving both financial and measurable impact outcomes, while specializing in capital-intensive, highly technical step-change solutions for planetary-scale problems like robotics for wind farm operations, large-scale carbon removal, and ecosystem restoration.
Snatched Ventures is a San Francisco-based early-stage venture capital firm backing DeepTech startups focused on sustainable innovation and operational transformation. It is led by a two-GP team combining corporate development and institutional investment management experience.
SOSV is a deep tech venture capital firm that makes first-check pre-seed investments and follow-on rounds in startups focused on human and planetary health, providing lab space and hands-on support at its US locations.
1955 Capital is an early-stage, thesis-driven venture firm founded in 2016 that invests in companies commercializing foundational science across biology, materials, energy, and computation.
Oxford Science Enterprises builds and funds companies based on cutting-edge research through a partnership with the University of Oxford, turning scientific breakthroughs into ventures.